Spineway Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Stephane Le Roux

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	5.9yrs
Board average tenure	no data

Recent management updates

Recent updates

CEO

Stephane Le Roux

no data

Tenure

€121,331

Compensation

Mr. Stephane Le Roux serves as the Chairman, CEO and President of Spineway Société Anonyme.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Stephane Le Roux	Chairman	no data	€121.33k	no data
Philippe Laurito	Director & CTO of Spineway Inc.	5.9yrs	€121.33k	no data
David Siegrist	Financial Director	no data	no data	no data
Agnès Mignani	Human Resources Manager	no data	no data	no data
Sandrine Carle	Deputy Chief Executive Officer	less than a year	no data	no data
Guillaume Bertet	Controller	no data	no data	no data
Mickaël Battisti	Controller	no data	no data	no data
Marie-Christelle Desmolles	Controller	no data	no data	no data
Jon Luedke	CEO of Spineway Inc.	5.9yrs	no data	no data

5.9yrs

Average Tenure

Experienced Management: 37S0's management team is seasoned and experienced (5.9 years average tenure).

Spineway Management

Management criteria checks 1/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Less than half of directors are independent

Recent updates

Less than half of directors are independent

Spineway SA to Report First Half, 2024 Results on Sep 24, 2024

Less than half of directors are independent

Spineway SA, Annual General Meeting, Mar 25, 2024

Full year 2023 earnings released

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway SA to Report Q4, 2023 Results on Feb 07, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Spineway Group Obtains 510(K) Clearance from the US Food and Drug Administration for its VEOS Spinal Fixation System

First half 2023 earnings released

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

New major risk - Shareholder dilution

New major risk - Financial position

Less than half of directors are independent

Spineway SA to Report First Half, 2023 Results on Sep 19, 2023

Spineway SA to Report Fiscal Year 2022 Results on Feb 09, 2023

Less than half of directors are independent

First half 2022 earnings released

Spineway SA (ENXTPA:ALSPW) agreed to acquire Spine Innovations SAS from LBO France.

Spineway SA, Annual General Meeting, May 18, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Spineway Société Anonyme, Annual General Meeting, Mar 23, 2022

Spineway Société Anonyme (ENXTPA:ALSPW) signed a memorandum of understanding to acquire Distimp.

Spineway in Negotiations to Acquire European Spinal Surgery Start-Up

Spineway Société Anonyme Announces Signature of A Partnership with Tsunami Medical

Spineway Société Anonyme, Annual General Meeting, Mar 08, 2021

Full year 2020 earnings released: €0.005 loss per share (vs €0.064 loss in FY 2019)

Spineway Société Anonyme to Report First Half, 2021 Results on Sep 03, 2021

CEO

Tenure

Compensation

Leadership Team

Average Tenure